Science & Enterprise subscription

Follow us on Twitter

  • Then "Day at the Races"
    about 13 hours ago
  • The Forward, America’s Leading Jewish News Organization, Goes All Digital. Third-generation subscriber here and wor…
    about 15 hours ago
  • Our friends at Statista reported on a survey on how the shutdown is affecting people in the U.S., this weekend's in…
    about 18 hours ago
  • New post on Science and Enterprise: Infographic – Americans Affected by Gov’t Shutdown #Science #Business
    about 18 hours ago
  • New contributed post on Science and Enterprise: Hands Off! Robots in Modern Medicine
    about 19 hours ago

Please share Science & Enterprise

Follow by Email
Visit Us

What Exactly Is Pharmaceutical Market Access?

– Contributed content –

Blue and white capsules

(Max Pixel)

9 March 2018. Medicine is one of the most important resources in the world. We are able to cure life threatening diseases with a simple pill or manage chronic annoyances with an inhaler. The medical industry over the years has performed some miracles in the world and we have all benefited from the clever minds who reside behind it, but there are more things to consider when creating a drug.

In the medical world, pharmaceutical market access is a term which is commonly thrown around from place to place, but what does it actually mean? In short, market access is a process which is out in place to ensure that any patient who is appropriate for receiving a certain medicine is able to receive it at a decent price.

Pharmaceutical market access makes things more fair in the medical industry to make sure that if someone needs treatment, they are able to get it without spending the earth on their prescription. The process of pharmaceutical market access has a few different factors to adhere to, to ensure that it runs as smoothly as possible.

The first process is that of paying. Of course, we all know that medical companies want to make a decent profit for the drugs they create, but sometimes the prices are ridiculous and out of control. The only way to stop them from being able to charge a huge chunk of money is to be smart and go through committees to keep the pricing reasonable. It will of course vary a little depending on the value of the drug and also the type of treatment, whether it is a pill or injection and also the local area.

R&D process is another part of this process which make sure that anyone who invests in the medicine is as successful as they can be. It ensures that investments are kept stable and helps to manage the cost.

The market access process doesn’t just stick to one country either, they have to make sure that this process is valid all over the globe. The reason for this is of course that no medicine should be simply limited to one market, and there must be equal opportunity for people to get the medicine they need anywhere. Because of this the process of market access will go through a series of different legislation and make sure that it agrees with every single country where the drug will be available to buy.

Market access therefore is an important part of the drugs manufacturing and distribution process because it ensures that the drug is available wherever it may be needed and also that there is a good enough supply to go around. It is likely that this will include looking at the number of people who suffer from a certain disease in different parts of the country and different countries, then supplying these drugs according to the demand. It can be a lengthy process but it will always be a crucial part of the medical industry.

*     *     *

Please share Science & Enterprise ...

Comments are closed.